Reading this on a mobile device? Try our optimized mobile version here:

February 15, 2013
Sign upForwardArchiveAdvertise
News for nuclear medicine and molecular imaging professionals
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at

  Top Story 
  • U.S., Canada in tentative HEU transportation deal
    U.S. and Canadian authorities, together with Georgia-based nuclear material packaging and transportation firm NAC International, have reached a tentative agreement for the transportation of 6,000 gallons of liquid highly enriched uranium from Canada to South Carolina. The liquid uranium was produced during the procedure to manufacture the medical isotope molybdenum-99. Once in the U.S., the HEU is set to be diluted for use as reactor fuel. The uranium transport is part of the National Nuclear Security Administration's Global Threat Reduction Initiative, which aims to limit nuclear materials that can be developed into nuclear weapons. Aiken Standard (S.C.) (2/14) LinkedInFacebookTwitterEmail this Story
The MEDRAD™ Intego™ is making personalized PET practical.
Clinicians are able to set weight-based dosing formulas to determine and administer an accurate, personalized dose for each unique patient. Precise delivery and dose-on-demand capabilities enable lower patient dosing, leading to better patient care. To learn more, click here.
  Clinical News & Research 
  Industry Report 
  • Adviser shares outlook for Nordion
    Nordion is exploring strategic next steps for the company, said adviser Howard Shainker, co-founder of Bow Street Capital Management. Strategic moves for Nordion could include spinning off assets, and any such move could take place in six months, Shainker said. Shainker also envisions many potential buyers should Nordion decide to sell. Reuters (2/13) LinkedInFacebookTwitterEmail this Story
  News from the Field 
  International Developments 
  • Sweden aligns medtech software policies with EU rules
    The Swedish Medical Products Agency has released new guidance outlining its process for regulating standalone software classified as medical devices in the country. The revised guidance is intended to clear up "remaining ambiguities" involving the regulation of such products as well as align it with the European Commission's rules on medtech software. Clinica (subscription required) (2/11) LinkedInFacebookTwitterEmail this Story
  Health Policy 
  • Coalition: Give feds power to negotiate Medicare drug prices
    The federal government should be able to negotiate the prices of Medicare drugs, says a liberal coalition. "It's ridiculous for Medicare to be paying drug companies two and three times as much money for drugs as other countries at a time when we are cutting essential programs," the Center for Economic and Policy Research's Dean Baker said. Pharmacy benefit managers and insurers have taken on that negotiation role, drugmakers say. The Hill/Healthwatch blog (2/14) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  • Using AI models may boost patient outcomes, curb costs
    The use of artificial intelligence algorithms in health care resulted in significantly better patient outcomes at a lower cost, researchers at Indiana University found. "The framework here easily outperforms the current treatment-as-usual, case-rate/fee-for-service models of health care," said researcher Casey C. Bennett. Computerworld (2/12) LinkedInFacebookTwitterEmail this Story
  From SNMMI 
  • Now available! Pathways: The Clinical Trials Network Newsletter
    The latest edition of Pathways is now available for download. Featured stories include "Do You Need an IND?" by Lucie Yang, M.D., Ph.D of FDA, "Investigational New Drug (IND) Submissions: We All Just Need to Share!" by Paula Jacobs, Ph.D of NCI, and the Biomarker Spotlight on F-18-Florbetapir. Plus, get the latest on the JSNM and SNMMI Collaboration. Download your copy of Pathways. LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

If you want to live a happy life, tie it to a goal. Not to people or things."
--Albert Einstein,
German-born theoretical physicist

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Account Director:   Meryl Harold   (202) 407-7828
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.®  Legal Information